MVM
PCVX icon

Medicxi Ventures Management’s Vaxcyte PCVX Stock Holding History

Medicxi Ventures Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,049,893
Closed -$53.5M – 6
2023
Q3 		$53.5M Sell
1,049,893
-265,542
-20% -$13.1M 17.09% 2
2023
Q2 		$65.7M Sell
1,315,435
-141,865
-10% -$6.72M 18.41% 2
2023
Q1 		$54.6M Hold
1,457,300
– – 23.4% 2
2022
Q4 		$69.9M Sell
1,457,300
-430,178
-23% -$16.9M 29.35% 1
2022
Q3 		$45.3M Hold
1,887,478
– – 18.86% 3
2022
Q2 		$41.1M Hold
1,887,478
– – 17.06% 3
2022
Q1 		$45.6M Hold
1,887,478
– – 12.35% 3
2021
Q4 		$44.9M Hold
1,887,478
– – 11.24% 4
2021
Q3 		$47.9M Hold
1,887,478
– – 10.42% 3
2021
Q2 		$42.5M Hold
1,887,478
– – 7.61% 3
2021
Q1 		$37.3M Hold
1,887,478
– – 21.71% 2
2020
Q4 		$50.1M Hold
1,887,478
– – 29.15% 2
2020
Q3 		$93.2M Hold
1,887,478
– – 44.51% 1
2020
Q2 		$59.7M Buy
+1,887,478
New +$60.7M 36.67% 2

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return